Myostatin has a detrimental effect on vascular cells and contributes to atherosclerosis progression [8,9,10] by favoring the migration of vascular smooth muscle cells (VSMCs) and the recruitment of monocytes, notably through MCP-1 upregulation in VMSCs and monocytes [8,9]. Here, MSTN is linked to atherosclerosis.